{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:18:18Z","timestamp":1791929898863,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR202111300436"],"award-info":[{"award-number":["ZR202111300436"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.intimp.2026.116437","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:43:08Z","timestamp":1773448988000},"page":"116437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Early CD201-high cancer-associated fibroblasts shape immunosuppression and suggest a therapeutic opportunity in triple-negative breast cancer"],"prefix":"10.1016","volume":"176","author":[{"given":"Min","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanli","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116437_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2026.116437_bb0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.116437_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.116437_bb0020","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.116437_bb0025","article-title":"Copper orchestrates triple-negative breast cancer progression via the STEAP3-dependent CDK16-JAK1 activation","volume":"639","author":"Duan","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.116437_bb0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/jtim-2025-0029","article-title":"CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer","volume":"13","author":"Dai","year":"2025","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.intimp.2026.116437_bb0035","article-title":"PRMT1-mediated PARP1 methylation drives lung metastasis and chemoresistance via P65 activation in triple-negative breast cancer","volume":"8","author":"Zhang","year":"2025","journal-title":"Research (Washington, D,C,)"},{"key":"10.1016\/j.intimp.2026.116437_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116437_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.116437_bb0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116437_bb0055","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","article-title":"Fibroblasts in cancer: Unity in heterogeneity","volume":"186","author":"Chhabra","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116437_bb0060","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116437_bb0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","article-title":"Activated fibroblasts in cancer: perspectives and challenges","volume":"41","author":"Caligiuri","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116437_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-024-01099-2","article-title":"Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects","volume":"32","author":"Cao","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2026.116437_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-020-00245-w","article-title":"Biomarkers for cancer-associated fibroblasts","volume":"8","author":"Han","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.intimp.2026.116437_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12964-023-01125-0","article-title":"What is new in cancer-associated fibroblast biomarkers?","volume":"21","author":"Zhao","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2026.116437_bb0085","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2967\/jnumed.123.265594","article-title":"Fibroblast activation protein inhibitor-based radionuclide therapies: current status and future directions","volume":"64","author":"Ora","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.intimp.2026.116437_bb0090","article-title":"Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116437_bb0095","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","article-title":"Meflin-positive Cancer-associated fibroblasts inhibit pancreatic carcinogenesis","volume":"79","author":"Mizutani","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116437_bb0100","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors","volume":"80","author":"Ford","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116437_bb0105","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1016\/j.cell.2025.06.036","article-title":"Procr+ chondroprogenitors sense mechanical stimuli to govern articular cartilage maintenance and regeneration","volume":"188","author":"Zhu","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116437_bb0110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41586-023-06725-x","article-title":"CD201+ fascia progenitors choreograph injury repair","volume":"623","author":"Correa-Gallegos","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116437_bb0115","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","article-title":"Cancer-associated fibroblasts in inflammation and antitumor immunity","volume":"29","author":"Kennel","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116437_bb0120","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2014-05-578328","article-title":"Endothelial cell protein C receptor: a multiliganded and multifunctional receptor","volume":"124","author":"Mohan Rao","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116437_bb0125","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41422-019-0225-9","article-title":"Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancers","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2026.116437_bb0130","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1074\/jbc.M117.814046","article-title":"Protein C receptor stimulates multiple signaling pathways in breast cancer cells","volume":"293","author":"Wang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116437_bb0135","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116437_bb0140","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2026.116437_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.116437_bb0150","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116437_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.intimp.2026.116437_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.116437_bb0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.intimp.2026.116437_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116437_bb0175","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2026.116437_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116437_bb0185","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.intimp.2026.116437_bb0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2026.116437_bb0195","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116437_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa176","article-title":"Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response","volume":"22","author":"Hu","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.intimp.2026.116437_bb0205","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","article-title":"TIP: a web server for resolving tumor immunophenotype profiling","volume":"78","author":"Xu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116437_bb0210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.intimp.2026.116437_bb0215","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Ann. Appl. Stat."},{"key":"10.1016\/j.intimp.2026.116437_bb0220","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.082099299","article-title":"Diagnosis of multiple cancer types by shrunken centroids of gene expression","volume":"99","author":"Tibshirani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116437_bb0225","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.1371\/journal.pbio.0020108","article-title":"Semi-supervised methods to predict patient survival from gene expression data","volume":"2","author":"Bair","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.intimp.2026.116437_bb0230","article-title":"Enhancing immuno-oncology investigations through multidimensional decoding of tumor microenvironment with IOBR 2.0","volume":"4","author":"Zeng","year":"2024","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.intimp.2026.116437_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1516","article-title":"The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116437_bb0240","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","article-title":"Classifying cancer-associated fibroblasts-the good, the bad, and the target","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116437_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1352615","article-title":"Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies","volume":"15","author":"Dziadek","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116437_bb0250","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1158\/0008-5472.CAN-24-3037","article-title":"Plasticity and functional heterogeneity of Cancer-associated fibroblasts","volume":"85","author":"Flynn","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116437_bb0255","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116437_bb0260","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116437_bb0265","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41423-022-00877-y","article-title":"Transcriptional regulation of the immune checkpoints PD-1 and CTLA-4","volume":"19","author":"Guo","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.116437_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105154","article-title":"T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle","volume":"104","author":"Lin","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2026.116437_bb0275","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116437_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46504-4","article-title":"Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas","volume":"15","author":"Broz","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116437_bb0285","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The interplay between extracellular matrix Remodeling and Cancer therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.116437_bb0290","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184846","article-title":"Checkpoint therapy in cancer treatment: progress, challenges, and future directions","volume":"134","author":"Bicak","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.116437_bb0295","article-title":"Advances and prospects of biomarkers for immune checkpoint inhibitors","volume":"5","author":"Yamaguchi","year":"2024","journal-title":"Cell Rep. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:11:37Z","timestamp":1790838697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":59,"alternative-id":["S156757692600281X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116437","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early CD201-high cancer-associated fibroblasts shape immunosuppression and suggest a therapeutic opportunity in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116437"}}